why choose us

First received: November 01, 2022

Clinical Trial: Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prostate Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate (POSH-MAP)

Brief Summary: To evaluate the preliminary efficacy of in reducing the frequency and severity of hot flashes in men on androgen deprivation therapy (ADT).

Read more